The Importance of Hepatitis B Virus Genome Diversity in Basal Core Promoter Region

Hepadnaviruses employ an unusual strategy for the production of enormous number of virions during replication which makes rapid and substantial genetic sequence changes and alterations. The pathogenesis and clearance of hepatitis B virus (HBV) infection are engaged by the selection and expression of viral mutants during virus-host interactions. Mutations in regulatory regions such as the basal core promoter (BCP) which is thought to be related to lower production of hepatitis B “e” antigen (HBeAg) directly affects the clinical presentation of liver disease. However, the molecular structure of these mutations in chronic carriers has not been adequately evaluated. In this review we evaluate the molecular aspect and pathologic basis of basal core promoter mutations.

[1]  F. Zoulim,et al.  Hepatitis B virus genotype and basal core promoter/precore mutations are associated with hepatitis B-related acute-on-chronic liver failure without pre-existing liver cirrhosis , 2010, Journal of viral hepatitis.

[2]  S. Wain-Hobson,et al.  APOBEC1 and APOBEC3 cytidine deaminases as restriction factors for hepadnaviral genomes in non-humans in vivo. , 2010, Journal of molecular biology.

[3]  M. Buti,et al.  Main mutations in the hepatitis B virus basic core promoter (A1762T/G1764A) before HBeAg loss are markers that identify patients who will require long‐term treatment , 2010, Alimentary pharmacology & therapeutics.

[4]  Z. Zou,et al.  Features and clinical implications of hepatitis B virus genotypes and mutations in basal core promoter/precore region in 507 Chinese patients with acute and chronic hepatitis B. , 2010, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[5]  H. Poustchi,et al.  Hepatocellular Carcinoma in the World and the Middle East , 2010, Middle East journal of digestive diseases.

[6]  H. Poustchi,et al.  The role of mutations in core protein of hepatitis B virus in liver fibrosis , 2009, Virology Journal.

[7]  G. Cao,et al.  Associations Between Hepatitis B Virus Mutations and the Risk of Hepatocellular Carcinoma: A Meta-Analysis , 2009, Journal of the National Cancer Institute.

[8]  M. Imamura,et al.  G-to-A hypermutation in hepatitis B virus (HBV) and clinical course of patients with chronic HBV infection. , 2009, The Journal of infectious diseases.

[9]  S. Wain-Hobson,et al.  Genetic Editing of HBV DNA by Monodomain Human APOBEC3 Cytidine Deaminases and the Recombinant Nature of APOBEC3G , 2009, PloS one.

[10]  R. Malekzadeh,et al.  Clinical significance of precore and core promoter mutations in genotype D hepatitis B‐related chronic liver disease , 2008, Journal of viral hepatitis.

[11]  J. Greeve,et al.  Hepatitis B: modern concepts in pathogenesis – APOBEC3 cytidine deaminases as effectors in innate immunity against the hepatitis B virus , 2008, Current opinion in infectious diseases.

[12]  B. McMahon Natural history of chronic hepatitis B - clinical implications. , 2008, Medscape journal of medicine.

[13]  Zhili Xu,et al.  Progressive Changes in Hepatoma Cells Stably Transfected with Hepatitis B Virus X Gene , 2008, Intervirology.

[14]  M. Mizokami,et al.  Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia , 2008, Journal of gastroenterology and hepatology.

[15]  Qiang Deng,et al.  Impact of hepatitis B virus basic core promoter mutations on T cell response to an immunodominant HBx‐derived epitope , 2007, Hepatology.

[16]  D. Glebe Recent advances in hepatitis B virus research: a German point of view. , 2007, World journal of gastroenterology.

[17]  S. Wain-Hobson,et al.  Interferon‐inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication , 2006, Hepatology.

[18]  M. Zali,et al.  T1764G1766 core promoter double mutants are restricted to Hepatitis B virus strains with an A1757 and are common in genotype D. , 2005, The Journal of general virology.

[19]  J. Ou,et al.  Regulation of Hepatitis B Virus Core Promoter by Transcription Factors HNF1 and HNF4 and the Viral X Protein , 2004, Journal of Virology.

[20]  C. Hunt,et al.  Clinical relevance of hepatitis B viral mutations , 2000, Hepatology.

[21]  M. Kew,et al.  The core promoter of hepatitis B virus , 1999, Journal of viral hepatitis.

[22]  S. Murakami Hepatitis B Virus X Protein: Structure, Function and Biology , 1999, Intervirology.

[23]  J. Mertz,et al.  Differential regulation of the pre-C and pregenomic promoters of human hepatitis B virus by members of the nuclear receptor superfamily , 1997, Journal of virology.

[24]  S. Günther,et al.  Naturally occurring hepatitis B virus genomes bearing the hallmarks of retroviral G-->A hypermutation. , 1997, Virology.

[25]  H. Schaller,et al.  Hepatitis B virus replication‐an update , 1996, Journal of viral hepatitis.

[26]  M. Nassal,et al.  A bulged region of the hepatitis B virus RNA encapsidation signal contains the replication origin for discontinuous first-strand DNA synthesis , 1996, Journal of virology.

[27]  M A Nowak,et al.  Viral dynamics in hepatitis B virus infection. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[28]  S. Mishiro,et al.  The precore/core promoter mutant (T1762A1764) of hepatitis B virus: clinical significance and an easy method for detection. , 1995, The Journal of general virology.

[29]  B. Lee,et al.  Putative Secondary Structure of Human Hepatitis B Viral X mRNA , 1995 .

[30]  O. Andrisani,et al.  The hepatitis B virus X protein targets the basic region-leucine zipper domain of CREB. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[31]  S. Kaneko,et al.  Transactivation of human hepatitis B virus X protein, HBx, operates through a mechanism distinct from protein kinase C and okadaic acid activation pathways. , 1994, Virology.

[32]  M. Micheli,et al.  Molecuar biology of hepatocellular carcinoma and hepatitis B virus association , 1992, International journal of clinical & laboratory research.

[33]  S. Günther,et al.  Naturally occurring variants of hepatitis B virus. , 1999, Advances in virus research.

[34]  S. Mishiro,et al.  Clinical implications of mutations C-to-T1653 and T-to-C/A/G1753 of hepatitis B virus genotype C genome in chronic liver disease , 1999, Archives of Virology.

[35]  M. Nassal Hepatitis B virus morphogenesis. , 1996, Current topics in microbiology and immunology.

[36]  W. Robinson,et al.  Molecular events in the pathogenesis of hepadnavirus-associated hepatocellular carcinoma. , 1994, Annual review of medicine.